Traders sold shares of Amsurg Corp. (NASDAQ:AMSG) on strength during trading hours on Friday. $14.91 million flowed into the stock on the tick-up and $68.63 million flowed out of the stock on the tick-down, for a money net flow of $53.72 million out of the stock. Of all companies tracked, Amsurg Corp. had the 0th highest net out-flow for the day. Amsurg Corp. traded up $1.89 for the day and closed at $67.29

AMSG has been the topic of several analyst reports. Zacks Investment Research raised Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 target price on the stock in a report on Monday, July 11th. Barclays PLC initiated coverage on Amsurg Corp. in a report on Wednesday, June 1st. They set an “equal weight” rating and a $85.00 target price on the stock. Robert W. Baird reaffirmed a “buy” rating on shares of Amsurg Corp. in a report on Monday, May 16th. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Amsurg Corp. in a report on Friday, June 17th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 target price on shares of Amsurg Corp. in a report on Thursday, July 14th. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $93.91.

The firm has a market cap of $3.62 billion and a P/E ratio of 19.97. The company’s 50 day moving average is $69.92 and its 200 day moving average is $74.07.

Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.08 by $0.02. The business had revenue of $758.50 million for the quarter, compared to analyst estimates of $769.88 million. The company’s revenue was up 21.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.97 earnings per share. On average, equities research analysts anticipate that Amsurg Corp. will post $4.33 EPS for the current year.

In other news, insider Robert Jon Coward sold 7,500 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $63.65, for a total transaction of $477,375.00. Following the completion of the transaction, the insider now directly owns 97,507 shares of the company’s stock, valued at approximately $6,206,320.55. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

A hedge fund recently raised its stake in Amsurg Corp. stock. Dimensional Fund Advisors LP boosted its stake in shares of Amsurg Corp. (NASDAQ:AMSG) by 3.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,994,029 shares of the company’s stock after buying an additional 92,088 shares during the period. Dimensional Fund Advisors LP owned about 6.27% of Amsurg Corp. worth $227,552,000 at the end of the most recent quarter.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.